Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01749371 · ClinicalTrials.gov registry record · Phase 2

Vitamin E Supplementation in Burned Patients

A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
Phase 2
Development phase
31
Enrollment target

NCT01749371 is a Phase 2 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 31 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01749371, a Phase 2 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
Phase 2
Development phase
31 participants
Enrollment target

Study Summary

A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of burn injury, including lung injury and impaired wound healing. This may improve the quality of life of the burn patient by preventing pathophysiology that may result from oxidative stress and may reduce hospital stay. Our research will lay the foundation for the future development of effective, safe, and economic therapeutic interventions to treat burn injury-associated metabolic abnormalities. Also, it will provide the basis for the development of supplemental regulations and pharmacotherapy to treat burn patients with vitamin E. The risks are very reasonable in relation to the anticipated benefits to our subjects because a) vitamin E is a simple vitamin that is abundant and approved for clinical use, and b) the subjects will be monitored consistently for the minimal increased tendency to bleed.

Interventions

  • DRUG Vitamin E

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2013-02
Est. Completion 2017-09
Phase Phase 2

What the Registry Record Tells You About NCT01749371

The ClinicalTrials.gov registry entry for NCT01749371 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Vitamin E is the first listed.

NCT01749371 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01749371 about?

NCT01749371 is a clinical study titled "Vitamin E Supplementation in Burned Patients". A dietary antioxidant, alpha-tocopherol, will be used to potentially attenuate Vitamin E short- and long-term losses in plasma and adipose, reverse the oxidative stress of burn injury and, in the process, decrease the secondary consequences of burn injury, including lung injury and impaired wound he...

What is the current status of trial NCT01749371?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2013-02. Estimated completion is 2017-09.

What interventions are being tested in trial NCT01749371?

The interventions under investigation include: Vitamin E (DRUG).

Who is sponsoring clinical trial NCT01749371?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.